Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)
- CUSIP: 92532F100
- Is VRTX overvalued or undervalued? Run a discounted cash flow (DCF) valuation analysis on VRTX
Who owns Vertex Pharmaceuticals Incorporated?
Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.
|Fund Name||Number of Shares||Share Valuation||As Of|
|OTR - Nominee Name for The State Teachers Retirement Board of Ohio||33.87M||$33.53M||March 31, 2015|
|Capital World Investors^||20.74M||$2.61B||Dec. 31, 2015|
|T. Rowe Price Associates||18.82M||$2.37B||Dec. 31, 2015|
|FMR||15.01M||$1.89B||Dec. 31, 2015|
|Wellington Management Company||14.86M||$1.87B||Dec. 31, 2015|
|Vanguard||14.50M||$1.82B||Dec. 31, 2015|
|JPMORGAN CHASE & CO||12.62M||$1.59B||Dec. 31, 2015|
|STATE STREET CORPORATION||9.80M||$1.23B||Dec. 31, 2015|
|Ameriprise Financial||9.59M||$1.21B||Dec. 31, 2015|
|ClearBridge Advisors||7.71M||$970.43M||Dec. 31, 2015|
|GOLDMAN SACHS||6.63M||$502.84M||Sept. 30, 2013|
|Jennison Associates||6.55M||$772.53M||March 31, 2015|
|BlackRock Fund Advisors||6.30M||$743.75M||March 31, 2015|
|BlackRock Institutional Trust Company, N.A.||6.25M||$786.65M||Dec. 31, 2015|
Who sold Vertex Pharmaceuticals Incorporated?
|Fund Name||Date Sold||Number of Shares Sold||Share Valuation|
|D. E. Shaw & Co||Dec. 31, 2010||7.48M||$262.12M|